-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Clinical progress for enterovirus 71 vaccines: what does the future hold?
Jing-Xin Li, Feng-Cai Zhu
Editorial: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Interview with Professor Pamela Kearns
Pamela Kearns
Interview: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Abiraterone acetate in the treatment of metastatic castration-resistant prostate cancer: review of the clinical data
D Schrijvers
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation